The use of direct oral anticoagulants in inherited thrombophilia
@article{Skelley2016TheUO, title={The use of direct oral anticoagulants in inherited thrombophilia}, author={Jessica W. Skelley and C. W. White and Angela R. Thomason}, journal={Journal of Thrombosis and Thrombolysis}, year={2016}, volume={43}, pages={24-30} }
To review the use of the direct oral anticoagulant (DOAC) agents in inherited thrombophilia based on the literature. MEDLINE, International Pharmaceutical Abstracts, and Google Scholar searches (1970–May 2016) were conducted for case reports, case series, retrospective cohorts, or clinical trials using the key words: protein C deficiency, protein S deficiency, antithrombin deficiency, activated protein C resistance, Factor V Leiden, hypercoagulable, NOACs, dabigatran, apixaban, rivaroxaban… CONTINUE READING
39 Citations
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
- Medicine
- Journal of the American Heart Association
- 2020
Rivaroxaban Treatment for Warfarin-Refractory Thrombosis in a Patient with Hereditary Protein S Deficiency
- Medicine
- Case reports in hematology
- 2018
- 4
- PDF
Rivaroxaban in Recurrent Ischemic Stroke Due to Protein S Deficiency: A Case Report
- Medicine
- Neurology and Therapy
- 2021
Management of antithrombin deficiency: an update for clinicians
- Medicine
- Expert review of hematology
- 2019
- 4
Efficacy of Oral Factor Xa Inhibitor for Venous Thromboembolism in a Patient with Antithrombin Deficiency
- Medicine
- Internal medicine
- 2018
- 5
- PDF
Management of severe congenital protein C deficiency with a direct oral anticoagulant, edoxaban: A case report
- Medicine
- Pediatric blood & cancer
- 2019
- 4
Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta‐analysis
- Medicine
- Journal of thrombosis and haemostasis : JTH
- 2019
- 31
References
SHOWING 1-10 OF 53 REFERENCES
Use of New Oral Anticoagulants in Antiphospholipid Syndrome
- Medicine
- Current Rheumatology Reports
- 2013
- 57
The use of rivaroxaban in patients with antiphospholipid syndrome: A series of 12 cases.
- Medicine
- Thrombosis research
- 2015
- 56
New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis.
- Medicine
- Gastroenterology
- 2013
- 302
- PDF
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.
- Medicine
- Blood
- 2014
- 460
- PDF
Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
- Medicine
- Thrombosis research
- 2014
- 82
The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.
- Medicine
- Pharmacology & therapeutics
- 2011
- 94
- PDF
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
- Medicine
- The Lancet
- 1993
- 1,224
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.
- Medicine
- Blood
- 1998
- 375
- PDF
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
- Medicine
- Thrombosis and haemostasis
- 2014
- 90